Gottschalk Emily's Form 4 filing
Anixa Biosciences Inc (ANIX) · filed Jul 16, 2021
- Accession no.
- 0001493152-21-017013
- Filed
- Jul 16, 2021
- Trade date
- Jul 15, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $79.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gottschalk EmilyCIK 0001791108 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Common Stock | PPurchaseAcquired | +20,065 | $3.96 | +$79,457.4 | 45,665 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.